Alzheimer Disease Clinical Research Studies

Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Status: Enrolling
Updated: 1/4/2013

Banner Alzheimer Institute

mi

from

Phoenix, AZ

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Status: Enrolling
Updated: 1/4/2013

Meridien Research

mi

from

St Petersburg, FL

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Double-Blind, Positive Comparator, Randomized, Parallel Study of Efficacy, Safety, and Tolerability of AZD3480 (TC-1734-226) as Monotherapy in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Status: Enrolling
Updated: 1/4/2013

MD Clinical

mi

from

Hallandale Beach, FL

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808

A Phase 0, Open Label, Non-Randomized, Multi-Center, Exploratory and Safety Study of [F-18]T808

Status: Enrolling
Updated: 2/15/2013

University of California, Irvine

mi

from

Irvine, CA

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

A Phase 0, Open Label, Non-randomized, Multi-center Exploratory and Safety Study of [F-18]T807

Status: Enrolling
Updated: 2/15/2013

University of California, Irvine

mi

from

Irvine, CA

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Fresno, CA

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Long Beach, CA

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

San Francisco, CA

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Hamden, CT

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Delray Beach, FL

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Orlando, FL

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Tampa, FL

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

West Palm Beach, FL

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Elk Grove Village, IL

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Staten Island, NY

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Status: Enrolling
Updated: 3/6/2013

Clinical Research Facility

mi

from

Bennington, VT

Metformin in Amnestic Mild Cognitive Impairment

Metformin in the Prevention of Alzheimer's Disease

Status: Enrolling
Updated: 3/13/2013

Columbia University Medical Center

mi

from

New York, NY

A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease

A Safety, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects and Patients Diagnosed With Alzheimer's Disease

Status: Enrolling
Updated: 3/14/2013

Clinical Research Facility

mi

from

American Fork, UT

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of AAB-003 (PF-05236812) In Subjects With Mild To Moderate Alzheimer's Disease

Status: Enrolling
Updated: 3/27/2013

Pfizer Investigational Site

mi

from

Los Angeles, CA

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of AAB-003 (PF-05236812) In Subjects With Mild To Moderate Alzheimer's Disease

Status: Enrolling
Updated: 3/27/2013

Pfizer Investigational Site

mi

from

Atlantis, FL

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of AAB-003 (PF-05236812) In Subjects With Mild To Moderate Alzheimer's Disease

Status: Enrolling
Updated: 3/27/2013

Pfizer Investigational Site

mi

from

Atlanta, GA

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive, Multiple Ascending Dose Study Of The Safety, Tolerability And Pharmacokinetics Of AAB-003 (PF-05236812) In Subjects With Mild To Moderate Alzheimer's Disease

Status: Enrolling
Updated: 3/27/2013

Pfizer Investigational Site

mi

from

Baltimore, MD

Clinical Research Trials Archive – Closed Trials

Zip code

Condition

We've found

5,401

archived clinical trials in

Alzheimer Disease

Clinical Research Trials Archive – Closed Trials

Zip code

Condition

We've found 5,401 archived clinical trials in Alzheimer Disease

Select your condition

Common Conditions

All Conditions

We've found

5,401

archived clinical trials in

Alzheimer Disease